Hypocalcemic effect of phentolamine

Area of Science:

• Endocrinology
• Pharmacology
• Mineral Metabolism

Background:

• Phentolamine is an alpha-adrenergic blocker.
• Calcitonin is a hormone that regulates calcium levels.
• The effects of phentolamine on calcium and phosphate metabolism are not well understood.

Purpose of the Study:

• To investigate the effects of phentolamine on calcium and phosphate metabolism in rats.
• To elucidate the mechanism of action of phentolamine in altering calcium levels.

Main Methods:

• Young female rats were administered varying doses of phentolamine intraperitoneally.
• Experiments included bilateral nephrectomy and thyroparathyroidectomy.
• 45Ca labeling was used to assess bone resorption.
• Tolazoline was used to investigate the role of alpha-adrenergic receptors.

Main Results:

• Phentolamine administration induced hypocalcemia and hypophosphatemia.
• The hypocalcemic effect peaked at one hour and normalized by three hours post-injection.
• Nephrectomy did not abolish the hypocalcemic effect.
• Thyroparathyroidectomy inhibited the hypocalcemic activity.
• Phentolamine was found to inhibit bone resorption.
• Alpha-adrenergic blockade by tolazoline did not affect plasma calcium.

Conclusions:

• Phentolamine's hypocalcemic and hypophosphatemic effects resemble those of calcitonin.
• The drug's action is not mediated by increased renal calcium excretion.
• Thyroparathyroidal involvement is suggested.
• Phentolamine inhibits bone resorption, contributing to hypocalcemia.